换一批The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.
第一作者：
Thomas,Powles
第一单位：
Bart Cancer Institute, Queen Mary University of London, St Bartholomew's Hospital London, UK.
作者：
医学主题词
成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);癌, 肾细胞(Carcinoma, Renal Cell);化学疗法, 辅助(Chemotherapy, Adjuvant);临床试验, Ⅱ期(主题)(Clinical Trials, Phase II as Topic);疾病恶化(Disease Progression);无病生存(Disease-Free Survival);用药计划表(Drug Administration Schedule);女(雌)性(Female);人类(Humans);吲哚类(Indoles);Kaplan-Meiers评估(Kaplan-Meier Estimate);肾肿瘤(Kidney Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤辅助疗法(Neoadjuvant Therapy);肾切除术(Nephrectomy);病人遴选(Patient Selection);比例危险度模型(Proportional Hazards Models);前瞻性研究(Prospective Studies);蛋白激酶抑制剂(Protein Kinase Inhibitors);吡咯类(Pyrroles);危险性评估(Risk Assessment);危险因素(Risk Factors);存活率(Survival Rate);时间因素(Time Factors);治疗结果(Treatment Outcome)
DOI
10.1016/j.eururo.2011.05.028
PMID
21612860
发布时间
2018-12-01
- 浏览14
European urology
448-54页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
